ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,235.00
-0.32%
S&P ASX All Technology
3,849.60
-0.26%
Brent Oil
74.095
0.64%
US Dollar vs AUD
1.60942
0.17%
Bitcoin
91,789.34
-1.85%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Eterna Therapeutics Inc (ERNA) Share Price

Eterna Therapeutics Inc

Eterna Therapeutics Inc (ERNA)

Is $ul-sh Bd A
0.3222
0.0692
( 27.35% )
Updated: 03:24:43
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.3222
Bid
0.3093
Offer
0.325
Volume
729,171
0.2701 Day's Range 0.325
0.2212 52 Week Range 2.625
Market Cap
16.553M
Previous Close
0.253
Open
0.2799
Last Trade
120
@
0.3222
Last Trade Time
03:24:43
Financial Volume
US$ 213,151
VWAP
0.292319
Average Volume (3m)
761,853
Shares Outstanding
51,374,713
Dividend Yield
-
PE Ratio
-0.71
Earnings Per Share (EPS)
-0.42
Revenue
68k
Net Profit
-21.68M

About Eterna Therapeutics Inc

Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. Show more

Sector
Pharmaceutical Preparations
Industry
Television Broadcast Station
Website
eternatx.com
Headquarters
Wilmington, Delaware, USA
Founded
2022
Eterna Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERNA. The last closing price for Eterna Therapeutics was US$0.25. Over the last year, Eterna Therapeutics shares have traded in a share price range of US$ 0.2212 to US$ 2.625.

Eterna Therapeutics currently has 51,374,713 shares in issue. The market capitalisation of Eterna Therapeutics is US$13 million. Eterna Therapeutics has a price to earnings ratio (PE ratio) of -0.71.

Ask ADVFN Intelligence (AI)

ERNA Latest News

More News

Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate’s (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models

CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA) today announced it will investigate the ability of its lead iMSC-based cell therapy (ERNA-101) to induce...

04 December 2024
GlobeNewswire Inc.

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program

CAMBRIDGE, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics, Inc. (Nasdaq: ERNA), a leader in cell therapies, today announced that its Board of Directors has authorized a stock...

26 November 2024
GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]

19 November 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

19 November 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

18 November 2024
Edgar (US Regulatory)

Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing

CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that it has regained compliance with Nasdaq for continued...

15 November 2024
GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities

14 November 2024
Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities

14 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 November 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.068226.85039370080.2540.340.2310453317870.26491547CS
4-0.1228-27.5955056180.4450.47460.221220737450.30851561CS
12-0.6878-68.0990099011.011.250.22127618530.3505462CS
26-1.4378-81.69318181821.762.6250.22123634670.38576369CS
52-1.5478-82.77005347591.872.6250.22121873780.42056802CS
156-3.8778-92.32857142864.27.150.22121101451.21691029CS
260-3.8778-92.32857142864.27.150.22121101451.21691029CS

ERNA - Frequently Asked Questions (FAQ)

What is the current Eterna Therapeutics share price?
The current share price of Eterna Therapeutics is US$ 0.3222
How many Eterna Therapeutics shares are in issue?
Eterna Therapeutics has 51,374,713 shares in issue
What is the market cap of Eterna Therapeutics?
The market capitalisation of Eterna Therapeutics is USD 13M
What is the 1 year trading range for Eterna Therapeutics share price?
Eterna Therapeutics has traded in the range of US$ 0.2212 to US$ 2.625 during the past year
What is the PE ratio of Eterna Therapeutics?
The price to earnings ratio of Eterna Therapeutics is -0.71
What is the cash to sales ratio of Eterna Therapeutics?
The cash to sales ratio of Eterna Therapeutics is 230.77
What is the reporting currency for Eterna Therapeutics?
Eterna Therapeutics reports financial results in USD
What is the latest annual turnover for Eterna Therapeutics?
The latest annual turnover of Eterna Therapeutics is USD 68k
What is the latest annual profit for Eterna Therapeutics?
The latest annual profit of Eterna Therapeutics is USD -21.68M
What is the registered address of Eterna Therapeutics?
The registered address for Eterna Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Eterna Therapeutics website address?
The website address for Eterna Therapeutics is eternatx.com
Which industry sector does Eterna Therapeutics operate in?
Eterna Therapeutics operates in the TELEVISION BROADCAST STATION sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXUNXU Inc
US$ 0.9792
(302.30%)
293.08M
WATTEnergous Corporation
US$ 1.54
(274.51%)
149.42M
INTZIntrusion Inc
US$ 5.55
(156.94%)
101.29M
CYNCYNGN Inc
US$ 1.53
(143.67%)
39.66M
VINCVincerx Inc
US$ 0.390884
(101.49%)
264.04M
ABPAbpro Holdings Inc
US$ 2.26
(-49.67%)
849.35k
TRAWTraws Pharma Inc
US$ 8.26
(-38.45%)
775.43k
LITMSnow Lake Resources Ltd
US$ 1.1792
(-26.30%)
40.09M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 66.34
(-25.01%)
7.1k
NVNINVNI Group Ltd
US$ 3.28
(-22.09%)
272.3k
NXUNXU Inc
US$ 0.9792
(302.30%)
296.49M
VINCVincerx Inc
US$ 0.390884
(101.49%)
264.37M
WATTEnergous Corporation
US$ 1.54
(274.51%)
150.16M
XTIAXTI Aerospace Inc
US$ 0.04039
(2.25%)
148.33M
INTZIntrusion Inc
US$ 5.55
(156.94%)
102.78M

ERNA Discussion

View Posts
Fairgrounds Fairgrounds 5 minutes ago
.3256
👍️0
tw0122 tw0122 29 minutes ago
.30 +
20%
👍️0
tw0122 tw0122 3 days ago
.32 the .20s will pay off
👍️0
tw0122 tw0122 2 weeks ago
$26-.27s looking better at .28
👍️0
tw0122 tw0122 3 weeks ago
Back in at .28 and they halt it
👍️0
tw0122 tw0122 3 weeks ago
The power of loading heavy at .28 beat down pays off
👍️0
tw0122 tw0122 4 weeks ago
Add .28s how low can she go longer term play perhaps 
👍️0
tw0122 tw0122 4 weeks ago
Back in at .30-.31 beat down price 
👍️0
glenn1919 glenn1919 4 weeks ago
ERNA........................................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 4 weeks ago
70% profit out in .70s  paid off to load .40s
👍️0
tw0122 tw0122 1 month ago
Add.40-.42
👍 1 🚀 1
tw0122 tw0122 1 month ago
Back in .45 still have share buyback in place 
👍 1 💯 1
tw0122 tw0122 1 month ago
.63 once it floats through weak resistance at .69-.71 off to dollar land $1
👍 1 🚀 1
tw0122 tw0122 1 month ago
.60 ..Even better off to $1 where it was last week 
👍 1 🚀 1
tw0122 tw0122 1 month ago
.55 now looking better
👍 1 🚀 1
tw0122 tw0122 1 month ago
In on .4999s hopefully bottom in at .51
👍️0
glenn1919 glenn1919 1 month ago
ERNA.......................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783

.

....................thx.....lost in the shuffle again..................
👍️0
tw0122 tw0122 1 month ago
1 million share buyback on this 2 million floater going to skyrocket..😵🥴🚀🚀🚀🚀🚀🚀🚀🚀

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase ProgramNovember 25 2024 - 8:30AM
👍️0
tw0122 tw0122 1 month ago
Right back to $1s with announcement...91- 1.28 next profit zone.. The effective date of the reverse stock split has not yet been determined and will be announced by the Company at least two business days prior to its implementation.
👍 1 🚀 1
tw0122 tw0122 1 month ago
Board is retarded you can't comment on DDC without getting permission to start board 
👍️0
Invest-in-America Invest-in-America 1 month ago
ERNA: Yep, been scrutinizing that puppy tonight. (And comment about DDC???)
👍 1 🔥 1
tw0122 tw0122 1 month ago
Cooling down $1.10 + 31%
👍️0
Invest-in-America Invest-in-America 1 month ago
ERNA: Up circa 46% in the Post-Market right now --- likely continued reaction to regaining NASDAQ compliance, YESTERDAY.
👍️0
glenn1919 glenn1919 3 months ago
ERNA.........................https://stockcharts.com/h-sc/ui?s=ERNA&p=W&b=5&g=0&id=p86431144783
👍️0

Your Recent History

NASDAQ
ERNA
Eterna Therapeutics
GATE
EVAUSDT
Evanesco Network
TSXV
REX
Orex Minerals
BIT
P1UCY5
NLBNPIT1UCY5 20991231 24...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads